Acquisition by Thierry Guillaudeux of 225000 shares of Kineta at 0.36 subject to Rule 16b-3
About 67% of Kineta's investor base is looking to short. The analysis of current outlook of investing in Kineta Inc suggests that many traders are alarmed regarding Kineta's prospects. The current market sentiment, together with Kineta's historical and current headlines, can help investors time the market. In addition, many technical investors use Kineta Inc stock news signals to limit their universe of possible portfolio assets.
Kineta |
Filed transaction by Kineta Inc Officer: Chief Scientific Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Kineta Fundamental Analysis
We analyze Kineta's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kineta using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kineta based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Institutions
Shares Owned By Institutions Comparative Analysis
Kineta is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Kineta Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Kineta stock to make a market-neutral strategy. Peer analysis of Kineta could also be used in its relative valuation, which is a method of valuing Kineta by comparing valuation metrics with similar companies.
Peers
Kineta Related Equities
PTIX | Protagenic Therapeutics | 32.14 | ||||
MLYS | Mineralys Therapeutics, | 10.96 | ||||
PHVS | Pharvaris | 0.85 | ||||
DYAI | Dyadic International | 0.71 | ||||
XOMAO | XOMA | 0.24 | ||||
CADL | Candel Therapeutics | 0.38 | ||||
ANTX | AN2 Therapeutics | 1.75 | ||||
ALVR | Allovir | 2.30 | ||||
DMAC | DiaMedica Therapeutics | 2.58 | ||||
RZLT | Rezolute | 2.90 | ||||
TPST | Tempest Therapeutics | 3.70 | ||||
ANEB | Anebulo Pharmaceuticals | 5.41 | ||||
FBRX | Forte Biosciences | 6.12 | ||||
MOLN | Molecular Partners | 6.96 | ||||
INKT | Mink Therapeutics | 7.85 | ||||
SILO | Silo Pharma | 10.29 | ||||
PEPG | PepGen | 18.86 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Kineta Stock
If you are still planning to invest in Kineta Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kineta's history and understand the potential risks before investing.
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |